MAP2K7 and neoplasm: It not only directly inhibits tumor cell proliferation by blocking the RAF/MEK/ERK-mediated signal transduction pathway but also indirectly inhibits tumor cell growth by blocking VEGFR and platelet-derived growth factor (PDGF) receptors, thereby cutting off tumor blood vessel formation.